APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Varicella Vaccine

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Selected research

Market Analysis & Forecast

Global Varicella Vaccine Market Analysis and Forecast 2026-2032

Report ID 174045190223 December 2025191 pages

Choose your research edition.

Industry ResearchVaricella Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Varicella Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Varicella Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varicella Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Varicella Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

Read the full market overview

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

This report presents an overview of global market for Varicella Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Varicella Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Varicella Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Varicella Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Varicella Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Varicella Vaccine sales, projected growth trends, production technology, application and end-user industry.

Varicella Vaccine Segment by Company

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Varicella Vaccine Segment by Type

Injection

Freeze-Dried Powder

Varicella Vaccine Segment by Application

Kids Injection

Adults Injection

Varicella Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varicella Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varicella Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varicella Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Varicella Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Varicella Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Freeze-Dried Powder Major Manufacturers Table 4. Global Varicella Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Kids Injection Major Manufacturers Table 6. Adults Injection Major Manufacturers Table 7. Varicella Vaccine Industry Trends Table 8. Varicella Vaccine Industry Drivers Table 9. Varicella Vaccine Industry Opportunities and Challenges Table 10. Varicella Vaccine Industry Restraints Table 11. Global Varicella Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Varicella Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Varicella Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Varicella Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Varicella Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Varicella Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Varicella Vaccine Sales by Region (2021-2026) & (M Doses) Table 18. Global Varicella Vaccine Sales by Region (2027-2032) & (M Doses) Table 19. Global Varicella Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Varicella Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Varicella Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Varicella Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Varicella Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Varicella Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Varicella Vaccine Sales Price (USD/Dose) of Manufacturers (2021-2026) Table 26. Global Varicella Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Varicella Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Varicella Vaccine Manufacturers, Product Type & Application Table 29. Global Varicella Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Varicella Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Varicella Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Varicella Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Varicella Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Varicella Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Varicella Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Varicella Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 39. Global Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 40. Global Varicella Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Varicella Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Varicella Vaccine Price by Type (2021-2026) & (USD/Dose) Table 43. Global Varicella Vaccine Price by Type (2027-2032) & (USD/Dose) Table 44. Global Varicella Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Varicella Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Varicella Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Varicella Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Varicella Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Varicella Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 51. Global Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 52. Global Varicella Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Varicella Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Varicella Vaccine Price by Application (2021-2026) & (USD/Dose) Table 55. Global Varicella Vaccine Price by Application (2027-2032) & (USD/Dose) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 59. Merck Varicella Vaccine Product Portfolio Table 60. Merck Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 64. GSK Varicella Vaccine Product Portfolio Table 65. GSK Recent Development Table 66. Shanghai Institute Company Information Table 67. Shanghai Institute Business Overview Table 68. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 69. Shanghai Institute Varicella Vaccine Product Portfolio Table 70. Shanghai Institute Recent Development Table 71. BCHT Company Information Table 72. BCHT Business Overview Table 73. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 74. BCHT Varicella Vaccine Product Portfolio Table 75. BCHT Recent Development Table 76. Changsheng Company Information Table 77. Changsheng Business Overview Table 78. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 79. Changsheng Varicella Vaccine Product Portfolio Table 80. Changsheng Recent Development Table 81. Keygen Company Information Table 82. Keygen Business Overview Table 83. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 84. Keygen Varicella Vaccine Product Portfolio Table 85. Keygen Recent Development Table 86. Green Cross Company Information Table 87. Green Cross Business Overview Table 88. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 89. Green Cross Varicella Vaccine Product Portfolio Table 90. Green Cross Recent Development Table 91. Biken Company Information Table 92. Biken Business Overview Table 93. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 94. Biken Varicella Vaccine Product Portfolio Table 95. Biken Recent Development Table 96. North America Varicella Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Varicella Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 99. North America Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 100. North America Varicella Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 101. North America Varicella Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 102. North America Varicella Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Varicella Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 105. North America Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 106. North America Varicella Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 107. North America Varicella Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 108. North America Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Varicella Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America Varicella Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 112. North America Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 113. North America Varicella Vaccine Sales by Country (2027-2032) & (M Doses) Table 114. North America Varicella Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 115. North America Varicella Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 116. United States Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Canada Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Mexico Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Europe Varicella Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Varicella Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 122. Europe Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 123. Europe Varicella Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 124. Europe Varicella Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 125. Europe Varicella Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Varicella Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 128. Europe Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 129. Europe Varicella Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 130. Europe Varicella Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 131. Europe Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Varicella Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Varicella Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 135. Europe Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 136. Europe Varicella Vaccine Sales by Country (2027-2032) & (M Doses) Table 137. Europe Varicella Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 138. Europe Varicella Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 139. Germany Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 140. France Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 141. U.K. Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Italy Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Russia Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Spain Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 146. Switzerland Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Sweden Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Poland Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 149. China Varicella Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 150. China Varicella Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 151. China Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 152. China Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 153. China Varicella Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 154. China Varicella Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 155. China Varicella Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 156. China Varicella Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 157. China Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 158. China Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 159. China Varicella Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 160. China Varicella Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 161. Asia Varicella Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Varicella Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 164. Asia Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 165. Asia Varicella Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 166. Asia Varicella Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 167. Asia Varicella Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Varicella Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 170. Asia Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 171. Asia Varicella Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 172. Asia Varicella Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 173. Asia Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Varicella Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Varicella Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 177. Asia Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 178. Asia Varicella Vaccine Sales by Country (2027-2032) & (M Doses) Table 179. Asia Varicella Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 180. Asia Varicella Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 181. Japan Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 182. South Korea Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 183. India Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Australia Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Taiwan Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Varicella Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Varicella Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 190. SAMEA Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 191. SAMEA Varicella Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 192. SAMEA Varicella Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 193. SAMEA Varicella Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Varicella Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 196. SAMEA Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 197. SAMEA Varicella Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 198. SAMEA Varicella Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 199. SAMEA Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Varicella Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Varicella Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 203. SAMEA Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 204. SAMEA Varicella Vaccine Sales by Country (2027-2032) & (M Doses) Table 205. SAMEA Varicella Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 206. SAMEA Varicella Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 207. Brazil Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Argentina Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Chile Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Colombia Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Peru Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Israel Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 214. UAE Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Turkey Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Iran Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Egypt Varicella Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Varicella Vaccine Distributors List Table 221. Varicella Vaccine Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Varicella Vaccine Image Figure 2. Global Varicella Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varicella Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Freeze-Dried Powder Image Figure 6. Global Varicella Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Varicella Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Kids Injection Image Figure 9. Adults Injection Image Figure 10. Global Varicella Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Varicella Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Varicella Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Varicella Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Varicella Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Varicella Vaccine Sales (2021-2032) & (M Doses) Figure 16. Global Varicella Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Varicella Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Varicella Vaccine Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Varicella Vaccine Sales YoY (2021-2032) & (M Doses) Figure 20. China Varicella Vaccine Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Varicella Vaccine Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Varicella Vaccine Sales YoY (2021-2032) & (M Doses) Figure 23. Global Varicella Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Varicella Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Varicella Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Varicella Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Varicella Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Varicella Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Varicella Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Varicella Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Varicella Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Varicella Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Varicella Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Varicella Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Varicella Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Varicella Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Varicella Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Varicella Vaccine Sales Share by Type (2021-2032) Figure 40. North America Varicella Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Varicella Vaccine Sales Share by Application (2021-2032) Figure 42. North America Varicella Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Varicella Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Varicella Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Varicella Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Varicella Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Varicella Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Varicella Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Varicella Vaccine Sales Share by Country (2021-2032) Figure 50. China Varicella Vaccine Revenue Share by Type (2021-2032) Figure 51. China Varicella Vaccine Sales Share by Type (2021-2032) Figure 52. China Varicella Vaccine Revenue Share by Application (2021-2032) Figure 53. China Varicella Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Varicella Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Varicella Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Varicella Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Varicella Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Varicella Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Varicella Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Varicella Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Varicella Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Varicella Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Varicella Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Varicella Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Varicella Vaccine Sales Share by Country (2021-2032) Figure 66. Varicella Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Varicella Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-Dried Powder
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Merck
  • GSK
  • Shanghai Institute
  • BCHT
  • Changsheng
  • Keygen
  • Green Cross
  • Biken

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Varicella Vaccine Market by Type
  3. 1.2.1 Global Varicella Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Freeze-Dried Powder
  6. 1.3 Varicella Vaccine Market by Application
  7. 1.3.1 Global Varicella Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Kids Injection
  9. 1.3.3 Adults Injection
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Varicella Vaccine Market Dynamics
  1. 2.1 Varicella Vaccine Industry Trends
  2. 2.2 Varicella Vaccine Industry Drivers
  3. 2.3 Varicella Vaccine Industry Opportunities and Challenges
  4. 2.4 Varicella Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Varicella Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Varicella Vaccine Revenue by Region
  3. 3.2.1 Global Varicella Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Varicella Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Varicella Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Varicella Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Varicella Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Varicella Vaccine Sales by Region
  9. 3.4.1 Global Varicella Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Varicella Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Varicella Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Varicella Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Varicella Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Varicella Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Varicella Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Varicella Vaccine Sales by Manufacturers
  6. 4.2.1 Global Varicella Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Varicella Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Varicella Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Varicella Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Varicella Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Varicella Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Varicella Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Varicella Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Varicella Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Varicella Vaccine Tier 1, Tier 2, and Tier 3
5 Varicella Vaccine Market by Type
  1. 5.1 Global Varicella Vaccine Revenue by Type
  2. 5.1.1 Global Varicella Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Varicella Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Varicella Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Varicella Vaccine Sales by Type
  6. 5.2.1 Global Varicella Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Varicella Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Varicella Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Varicella Vaccine Price by Type
6 Varicella Vaccine Market by Application
  1. 6.1 Global Varicella Vaccine Revenue by Application
  2. 6.1.1 Global Varicella Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Varicella Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Varicella Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Varicella Vaccine Sales by Application
  6. 6.2.1 Global Varicella Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Varicella Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Varicella Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Varicella Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Varicella Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Varicella Vaccine Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Shanghai Institute
  14. 7.3.1 Shanghai Institute Company Information
  15. 7.3.2 Shanghai Institute Business Overview
  16. 7.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Institute Varicella Vaccine Product Portfolio
  18. 7.3.5 Shanghai Institute Recent Developments
  19. 7.4 BCHT
  20. 7.4.1 BCHT Company Information
  21. 7.4.2 BCHT Business Overview
  22. 7.4.3 BCHT Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BCHT Varicella Vaccine Product Portfolio
  24. 7.4.5 BCHT Recent Developments
  25. 7.5 Changsheng
  26. 7.5.1 Changsheng Company Information
  27. 7.5.2 Changsheng Business Overview
  28. 7.5.3 Changsheng Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changsheng Varicella Vaccine Product Portfolio
  30. 7.5.5 Changsheng Recent Developments
  31. 7.6 Keygen
  32. 7.6.1 Keygen Company Information
  33. 7.6.2 Keygen Business Overview
  34. 7.6.3 Keygen Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Keygen Varicella Vaccine Product Portfolio
  36. 7.6.5 Keygen Recent Developments
  37. 7.7 Green Cross
  38. 7.7.1 Green Cross Company Information
  39. 7.7.2 Green Cross Business Overview
  40. 7.7.3 Green Cross Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Green Cross Varicella Vaccine Product Portfolio
  42. 7.7.5 Green Cross Recent Developments
  43. 7.8 Biken
  44. 7.8.1 Biken Company Information
  45. 7.8.2 Biken Business Overview
  46. 7.8.3 Biken Varicella Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biken Varicella Vaccine Product Portfolio
  48. 7.8.5 Biken Recent Developments
8 North America
  1. 8.1 North America Varicella Vaccine Market Size by Type
  2. 8.1.1 North America Varicella Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Varicella Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Varicella Vaccine Price by Type (2021-2032)
  5. 8.2 North America Varicella Vaccine Market Size by Application
  6. 8.2.1 North America Varicella Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Varicella Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Varicella Vaccine Price by Application (2021-2032)
  9. 8.3 North America Varicella Vaccine Market Size by Country
  10. 8.3.1 North America Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Varicella Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Varicella Vaccine Market Size by Type
  2. 9.1.1 Europe Varicella Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Varicella Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Varicella Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Varicella Vaccine Market Size by Application
  6. 9.2.1 Europe Varicella Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Varicella Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Varicella Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Varicella Vaccine Market Size by Country
  10. 9.3.1 Europe Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Varicella Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Varicella Vaccine Market Size by Type
  2. 10.1.1 China Varicella Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Varicella Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Varicella Vaccine Price by Type (2021-2032)
  5. 10.2 China Varicella Vaccine Market Size by Application
  6. 10.2.1 China Varicella Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Varicella Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Varicella Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Varicella Vaccine Market Size by Type
  2. 11.1.1 Asia Varicella Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Varicella Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Varicella Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Varicella Vaccine Market Size by Application
  6. 11.2.1 Asia Varicella Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Varicella Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Varicella Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Varicella Vaccine Market Size by Country
  10. 11.3.1 Asia Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Varicella Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Varicella Vaccine Market Size by Type
  2. 12.1.1 SAMEA Varicella Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Varicella Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Varicella Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Varicella Vaccine Market Size by Application
  6. 12.2.1 SAMEA Varicella Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Varicella Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Varicella Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Varicella Vaccine Market Size by Country
  10. 12.3.1 SAMEA Varicella Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Varicella Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Varicella Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Varicella Vaccine Value Chain Analysis
  2. 13.1.1 Varicella Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Varicella Vaccine Production Mode & Process
  6. 13.2 Varicella Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Varicella Vaccine Distributors
  9. 13.2.3 Varicella Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst